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This paper shows that the effects of causal SNPs on lifespan, estimated through GWAS,
may be confounded and the genetic structure of the study population may be responsible
for this effect. Simulation experiments show that levels of linkage disequilibrium (LD) and
other parameters of the population structure describing connections between two causal
SNPs may substantially influence separate estimates of the effect of the causal SNPs on
lifespan. This study suggests that differences in LD levels between two causal SNP loci
within two study populations may contribute to the failure to replicate previous GWAS
findings. The results of this paper also show that successful replication of the results of
genetic association studies does not necessarily guarantee proper interpretation of the
effect of a causal SNP on lifespan.
Keywords: linkage disequilibrium, population stratification, mortality selection, lack of replication, causal SNP,
longevity related traits, population genetic structure
INTRODUCTION
The results of many genome-wide association studies (GWAS) of complex traits suffer from a
lack of replication (Shen et al., 2005; Gorroochurn et al., 2007; Greene et al., 2009; Hart et al.,
2013; Ioannidis, 2015; Maxwell et al., 2015; Torrico et al., 2016). Differences in population genetic
structures among study populations are considered to be possible contributors to this problem
(Greene et al., 2009). One aspect of population structure—the differences in genetic frequencies
among subgroups of individuals comprising the population—was traditionally linked with the
effects of population stratification (Wacholder et al., 2000; Price et al., 2006, 2010). Another
one—the presence of linkage disequilibrium (LD) in many parts of the human genome including
those that contain causal SNPs—was actively exploited in GWAS of complex traits (Cantor et al.,
2010;Moore et al., 2010; Hayes, 2013).Methods of finemapping following the “discovery” phase are
used for evaluating causal SNPs (Clarke et al., 2007; Hassanein et al., 2010; Zapata, 2013; Kichaev
et al., 2014; Morris, 2014). One could expect that the non-replication problem due to differences
in LD patterns among study populations in GWAS would disappear if the detected marker SNP
is a causal one, i.e., if it contributes to the variability of a trait. It turns out that the differences
in LD levels around a functional SNP may still contribute to the non-replication problem. The
estimated associations in this case depend on whether the detected functional SNP is in LD
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with another functional SNP, the effects of these SNPs on the
trait in the absence of LD (pure effects), and on the level of LD
between corresponding SNP loci. This property has important
consequences for interpretation of the results of genetic analyses
of complex traits. In the presence of LD the estimated effects of
a causal SNP may be spurious and may incorrectly characterize
the biological relationships between the SNP and the trait. In
contrast the pure effect of a given causal SNP estimated in the
absence of LD with other such SNPs may correctly characterize
the biological connections between the SNP and the trait.
Therefore, for example, performing genetic analyses of African
populations (that have lower levels of LD patterns for many SNP
pairs than populations of European origin) has the potential
to reduce bias in the estimated effects of functional SNPs on
a trait caused by the presence of LD between functional loci
(Shifman et al., 2003). This condition is, however, not sufficient
because of the possible presence of hidden gene/gene interaction
effects, gene/environment correlations, and gene/environment
interaction effects (Ukraintseva et al., 2016).
Human lifespan and many other aging, health and longevity
related traits are multifactorial phenotypes, that is, they
are affected by many genetic and non-genetic factors. The
relationships between genes and these phenotypes have special
features that distinguish them from other complex traits,
influence methods of their genetic analyses, and affect the
interpretation of the research results. The genetic variants that
influence aging, health, and longevity related traits generate
age dependent changes in the population genetic structure, i.e.,
changes in the frequencies of genetic variants and in the levels
of linkage disequilibrium (LD) among them. This feature has
important implications for studies focused on the replication of
GWAS research findings: Independent populations involved in
such studies often have different genetic structures, due in part
to the differences in the population age distribution at the time
of biospecimen collection. As a result, the frequencies of the
genetic variants associated with these traits and their LD patterns
may differ even if the genetic structures in the corresponding
population cohorts were the same at birth.
Detecting statistically significant associations of genetic
variants with complex traits is not the end of the genetic analyses.
One reason is that the relationship between a detected marker
SNP and the complex trait of interest is not, necessarily, a
causal one. More often these relationships serve as proxies
for the real effect of some unobserved causal SNPs [due to
linkage disequilibrium (LD) between the marker and causal
SNPs], and, hence, do not have a direct biological effect on the
phenotype. To generate insights about the biological mechanisms
responsible for the trait’s variability one has to identify the causal
SNPs responsible for the association signal. To identify such
SNPs a number of efficient fine-mapping procedures have been
recommended (Zaitlen et al., 2010; Hormozdiari et al., 2015).
The main limitation of existing methods is that they seek to
identify a single causal variant which is independent of (not in
LD with) other causal variants (Hormozdiari et al., 2014). Since
this is not sufficiently realistic, a new approach that allows for
efficient detection of multiple causal variants has been proposed
(Hormozdiari et al., 2014). The case where two or more causal
SNPs are in LD creates additional problems for interpretation of
the results of genetic association studies.
In this paper we show that the estimates of the effects of
a causal SNP on lifespan depend on the genetic structure of
the population under study (e.g., the level of LD of the SNP
with other causal SNPs). Genetic association studies of this trait
using data from populations with different LD levels are likely to
produce different results. We show that differences in population
genetic structures can explain why genetic variants favorable for
longevity in one population appear as harmful risk factors in
another population. Population structuremay also be responsible
for the age-specific effects of genetic variants on mortality risk.
Differences in genetic structures in distinct populations may be
responsible for the low level of replicability of GWAS of human
aging, health, and longevity related traits.
DATA AND METHODS
To show how the effects of differences in LD levels and other
parameters of the population genetic structure influence the
results of genetic association studies we consider lifespan as the
trait of interest and two causal SNP loci with minor and major
alleles at each locus. Accordingly we will use a simplemodel of the
genetic connections with lifespan that requires only dichotomous
genetic variables (e.g., this is the case when the minor alleles at
each locus have dominant genetic effects on lifespan). Extensions
for cases with SNP genotypes are straightforward. Let V1 = (0, 1)
and V2 = (0, 1) be the values of the genetic variants at these
loci, where “1” denotes the minor allele and “0” corresponds to
the major allele (see Figure 1S, Supplementary Materials). The
genetic variants affect survival through mortality risks specified
for haplotypes (i,j) where i = 0, 1 characterizes the presence
of major or minor alleles in the first SNP locus, and j = 0, 1
describes the presence of such alleles in the second SNP locus.
Denote by µij, i,j = (0, 1), the mortality risks for each of
four haplotypes. We assume for simplicity that these risks are
age-independent. Adding age dependence will not qualitatively
change our results. Let m00(t),m10(t),m01(t), and m11(t) be the
frequencies of corresponding haplotypes at age t ≥ t0, and
µ00,µ10,µ01,µ11 be the mortality risks for these haplotypes. The
minor allele frequencies m1(t) and m2(t) at any age t ≥ t0 are
defined asm1(t) = m10(t)+m11(t) andm2(t) = m01(t)+m11(t).
We assume that in the absence of LD at age t0 the minor allele
in the first locus has a positive association with lifespan (i.e., it
is a “longevity” allele), and the minor allele in the second locus
has a negative association with lifespan (i.e., it is a “vulnerability”
allele).
To make this possible we assume that mortality risks for the
haplotypes satisfy the inequalities:
µ10 < µ00 < µ11 < µ01 (1)
To minimize the effects of the mathematical representation of
the connections between the genetic factors and mortality on the
results of our simulation experiment we considered two models
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of mortality risks. For Model 1, we assumed that:
µ10 = µ00(1+R1),µ01 = µ00(1+R2), andµ11 = µ00(1+R1+R2)
(2)
where R1 and R2 could be called the increments to the haplotypes’
relative risks associated with the presence of minor alleles in the
first and second loci, respectively. To guarantee Equation (1) the
values of R1 and R2 have to satisfy inequalities:
−1 < R1 < 0,R2 > 0, and R1 + R2 > 0.
For Model 2, we assumed that:
µ10 = µ00H1,µ01 = µ00H2, and µ11 = µ00H1H2. (3)
These relative risks have to satisfy the inequalities:
H1 < 1,H2 > 1, and H1H2 > 1.
In our simulation experiments, we fix the initial frequencies
m1(t0) and m2(t0), specify values of R1 and R2 (or H1 and H2),
fix the initial levels of LD(t0), and run the models to calculate the
age trajectories of mortality rates for the carriers µ1(t) and non-
carriersµ0(t) of the minor allele in the first locus. The calculation
of the age trajectories of mortality rates for the carriers and non-
carriers of the minor allele in the first SNP locus, as well as the age
trajectories of other variables, are shown in the Supplementary
Materials.
RESULTS
The results of four simulation experiments with Model 1 are
shown in Figure 1. The corresponding model parameters are
presented in Table 1.
One can see from Figure 1 and Table 1 that the graphs
of the mortality rates shown in Figures 1A–C correspond to
the same initial values of the minor allele frequencies m1(t0)
and m2(t0) in the two SNP loci in each of three experiments
and the same (constant) values of µ00, R1, and R2. The latter
values are used for calculating mortality risks for haplotypes
(Equation 2). The differences in the initial LD levels and in
haplotype frequencies are responsible for the radical differences
in relationships between mortality rates for carriers and non-
carriers of the minor allele at the SNP1 locus (shown in Figure 1).
Figure 1A shows that the mortality rate for carriers of the minor
allele of SNP 1 is lower than that for non-carriers of this allele,
suggesting that this is a “longevity” allele. Figure 1B shows that
the mortality rate for carriers of the minor allele of SNP 1 is
higher than that for non-carriers of this allele, suggesting that
this is a “vulnerability” allele. Figure 1C shows that the mortality
rates for carriers and non-carriers of the minor allele of SNP
1 intersect: the harmful effect of the allele on mortality risk
at the initial age interval changed to a beneficial one later in
life. Figure 1D shows that mortality rates for carriers and non-
carriers of the minor allele of SNP 1 may intersect in the opposite
way: the beneficial effect of the allele onmortality risk at the initial
age interval changed to a harmful one later in life. The results of
analyses using Model 2 are similar to those of Model 1. They can
be found in Figure 2S in the Supplementary Materials.
DISCUSSION
In this paper we showed that the finding of an association of
lifespan with a functional SNP does not exclude the possibility
of non-replication due to differences in initial LD patterns
among study populations. The detected associations may differ
dramatically if the study populations have different LD patterns
around the functional SNP locus. This may happen if the LD
area includes one or more additional causal loci affecting the
same trait. We showed that in this case the difference in the LD
value may change the sign of the estimated genetic association
with mortality risks to the opposite direction. The possibility of
such a phenomenon was highlighted by Lin et al. (2007) who
provided examples of genetic variants that show such “flip-flop”
effects in genetic association studies. The authors performed
comprehensive simulation analyses of “static” cases in which LD
levels influence relative risks of corresponding genetic variants.
The results of their study provide us with valuable information
for proper interpretation of findings from genetic association
studies of risks of diseases whose occurrence does not affect
mortality risks. Additional analyses motivated by Lin et al. (2007)
showed that differences in frequencies of genetic variants may
also produce reversals of the effects of genetic variants on disease
risks (Zaykin and Shibata, 2008).We also showed that differences
in the LD levels and other parameters of population genetic
structure can change the signs of the genetic effects on longevity
related traits at different age intervals.
Despite their high relevance for many genetic association
studies, the “static” cases of LD effects on relative risks described
in Lin et al. (2007) and Zaykin and Shibata (2008) may be less
informative when studying the risks of chronic conditions (e.g.,
CVD, cancer) whose occurrences do influence mortality risk.
This is because genetic variants affecting such risks are involved
in mortality selection processes in which the most vulnerable
individuals in a population birth cohort tend to become sick
and die first. This process, in turn, generates age-related changes
in genotype (allele) frequencies, in values of disease risks for
carriers and non-carriers of selected genetic variants, as well as in
mortality risks. In particular, non-monotonic age trajectories of
the frequencies of selected alleles or genotypes (Yashin et al., 1999,
2000; Atzmon et al., 2006; Bergman et al., 2007) could result from
specific LD patterns. The estimated effects of genetic variants on
longevity related traits in populations that have different initial
LD levels between selected SNP loci or, more generally, different
genetic structures may differ dramatically. The age trajectories
of LD values between functional SNP loci may also change with
increasing age of the population cohorts.
Recently Ukraintseva et al. (2016) investigated possible causes
and mechanisms of paradoxical behaviors of genetic risk factors
including age-dependence of the effects of genetic variants
on disease and mortality risks. Such effects may result from
pleiotropic influences of a genetic variant on chronic health
disorders and on aging-related phenotypes. They can also be
caused by changes in the epistatic effects on mortality risk or in
the effects of interactions of genetic factors with environmental
conditions with increasing age. Each of these causes may result in
non-replication. In this paper we modeled another possible cause
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FIGURE 1 | Graphs of mortality rates for carriers (solid line) and non-carriers (dashed line) of the minor allele at the first SNP locus corresponding to
different levels of LD between the two loci and different haplotype frequencies in four simulation experiments with Model 1 of the genetic influence on
mortality rates. Model parameters corresponding to the graphs shown in (A–D) are represented in Table 1 in rows (A–D), respectively. Equations linking the
mortality rates for the carriers and non-carriers of the minor allele of the first SNP (shown in A–D of Figure 1) with the mortality risks for haplotypes are given on last
page of the Supplementary Materials.
TABLE 1 | Parameter values used in four simulation experiments with Model 1.
m1(t0) m2(t0) LD(t0) m00(t0) m10(t0) m01(t0) m11(t0) µ00 R1 R2
(A) 0.4 0.4 −0.16 0.2 0.4 0.4 0 0.07 −0.2 0.8
(B) 0.4 0.4 0.23 0.59 0.01 0.01 0.39 0.07 −0.2 0.8
(C) 0.4 0.4 0.13 0.49 0.11 0.11 0.29 0.07 −0.2 0.8
(D) 0.28 0.41 0.165 0.59 0 0.13 0.28 0.07 −0.35 0.4
m1 (t0 ) is the initial value of the minor allele frequency at the SNP1 locus; m2 (t0 ) is the initial value of the minor allele frequency at the SNP2 locus; LD(t0 ) is the initial value of linkage
disequilibrium between the SNP1 and SNP2 loci; m00 (t0 ) is the initial value of the haplotype (0, 0) frequency; m10 (t0 ) is the initial value of the haplotype (1, 0) frequency; m01 (t0 ) is the initial
value of the haplotype (0, 1) frequency; m11 (t0 ) is the initial value of the haplotype (1, 1) frequency; µ00 is the mortality risk for carriers of haplotype (00); R1 and R2 are the increments
to the haplotypes’ relative risks associated with the presence of minor alleles in the first and in the second loci, respectively. Mortality risks for haplotypes (0, 0), (1, 0), (0, 1), and (1, 1)
are calculated using equation (2).
for non-replication resulting from the differences in LD levels
between pairs of functional SNP loci, each of which is associated
with lifespan, in two populations. Taking the possibility of such
effects into account is crucial for proper interpretation of the
results of genetic analyses of complex traits.
The results presented in this paper will be highly relevant
to genetic studies of human aging, health, and longevity related
traits only if the assumed variability in LD values at different
locations of the human genome is common in populations used
for genetic association studies. Numerous studies show that LD
patterns vary from one population to the next at different areas
of the human genome. The differences in LD of lipid-associated
loci in different study populations and the implications of these
differences for genetic analyses across multiple populations were
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investigated in Teo and Sim (2010). Charles et al. (2014) provided
an overview of LD measures used in analyses of population
genetic structures and discussed their possible use in GWAS of
populations with discordant LD patterns. Sawyer et al. (2005)
analyzed LD patterns of selected genomic regions in diverse
populations and provided evidence of marked differences in
haplotype frequencies and in corresponding LD patterns. Liu
et al. (2013) emphasized that genetic analyses of admixed
populations may result in confounding due to different patterns
of genetic structure. Thomson and colleagues found differences
in LD patterns between populations of Hutterites and Europeans
(Thompson et al., 2010). The results of Koda and colleagues
suggest that some differences in the estimates of risk for coronary
heart disease can be explained by population differences in
haplotype frequencies of the PON1 haplotypes (Koda et al.,
2004). Lohmueller et al. (2006) found genetic variation in the
LD patterns in the G-protein coupled receptor kinase 4 (GRK4
gene). The product of this gene inhibits the dopamine receptor
D1 (DRD1). The LD patterns were found to be different in
SNPs related to 81 osteoporosis candidate genes (Kim et al.,
2007). Garner and Slatkin found extensive variation in the LD
patterns between a disease locus and one or two marker SNP
loci—even for closely linked loci (Garner and Slatkin, 2003).
They also found that the distribution of LD patterns between
common variants is strongly influenced by ancestral population
size.
Thus, the differences in the LD patterns among study
populations may result in misleading interpretations of the
biological mechanisms involved in trait regulation. Differences
in LD are likely to be present in study populations sampled in the
U.S. Many such populations contain mixtures of subpopulations
that migrated to the U.S. from different parts of the world. In
cases where the LD patterns in the study populations do not
coincide with those of the specific ethnicities in HAP/MAP or
other reference datasets, one may expect the results of genetic
association studies to be different. Estimation of the LD patterns
around specific SNP loci in the targeted study populations can
help one to better understand the sources of inconsistency in the
GWAS results.
The fact that the second functional SNP may be unobserved
(e.g., not included in the list of SNPs for genotyping) in
a given study population makes the results of traditional
replication analyses unpredictable and may result in a failure
to replicate earlier research findings. To reduce the chances of
non-replication due to differences in the LD patterns in studies
of independent populations, one has to conduct the replication
study using populations with similar patterns of LD around
specific targeted loci. This mean that different study populations
may be needed for replication of the research results concerning
the effects of different SNPs. Non-replication due to other (non-
LD) reasons may also occur. Dealing with these other sources
of non-replication will require different approaches (Ukraintseva
et al., 2016).
Figure 2 shows two distinct patterns of LD for white and black
male participants of the Multi-Ethnic Study of Atherosclerosis
(MESA) SNP Health Association Resource (SHARe), available
from dbGaP.
One can see from the figure that there are many more SNPs
that are in strong LD in the population of white males than in the
population of black males from the same study. The two SNPs
shown in this figure are rs2466792 and rs11854943 in gene FBN1
on chromosome 15. Theminor allele of the rs2466792 SNP (MAF
43.6%) reduces mortality risk (relative risk HR = 0.7; p-value
0.03) among black males MESA participants. The minor allele
of the rs11854943 SNP (MAF 10.7%) increases mortality risk
(relative risk HR = 1.5, p-value 0.04) among black males MESA
participants. Neither allele shows an association with lifespan
among white male MESA participants.
Although, the causes of the different effects of selected SNPs
on mortality risks between black and white males may include
influences of gene-gene and gene-environment interactions
which are not estimated in these analyses, the difference in LD
could also make substantial contributions to these differences,
as illustrated in Figure 3S. This figure shows age patterns of
mortality rates for carriers and non-carriers of minor alleles in
populations with different levels of LD. Panels “e, f ” of Figure
3S in this figure correspond to populations with higher and
lower LD values, respectively. The intersection of age patterns of
mortality risks for carriers and non-carriers of the minor allele
in panel “e” of Figure 3S indicates that the estimate of relative
risk using the Cox regression model over the entire age interval is
likely to be close to one (because differences between the curves
will tend to compensate each other), i.e., analyses will not show
statistically significant associations of this genetic variant with
lifespan. The two non-intersecting age patterns of mortality risks
for carriers (red line) and non-carriers (blue dashed line) of the
minor allele in the population with the lower initial value of LD
(panel “f” of Figure 3S) indicate that the differences in hazard
rates and hence in survival functions between these groups can be
estimated by statistical methods (e.g., using a Cox-type regression
model).
It is important to note that differences in the LD patterns may
be responsible for non-replication of the results of (non-genetic)
epidemiological studies. Such confounding may take place when
two or more causal SNP loci influence different phenotypes and
are in LD (Aissani, 2014). In this case, one phenotype will always
show its association with the other one in epidemiological studies
although such a connection may be not causal but induced
instead by the LD between the corresponding SNP loci. Further,
the use of one such phenotype as a covariate in a GWAS of
the second phenotype may substantially modify the estimate of
genetic association with the second trait. Different patterns of
LD among study populations are expected to produce different
confounding effects, jeopardizing proper interpretation of the
results of epidemiological studies.
The effect of the minor allele of a causal SNP (SNP1) on
lifespan is considered to be “pure” when it is estimated in a
population whose genetic structure does not have LD between
SNP1 and any other causal SNP. In the absence of other (e.g.,
non-genetic) confounders this effect characterizes the biological
connections between variations in SNP1 and lifespan. If in
some other population the causal SNP (SNP1) is in strong LD
with another causal SNP (SNP2), then its estimated effect on
lifespan in a new genetic association study is confounded and
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FIGURE 2 | Patterns of LD around rs2466792 and rs11854943 SNPs in gene FBN1 on chromosome 15 in populations of white and black male
participants of MESA. The SHARe genetic data were used in the LD analyses.
may be radically different from the pure effect (e.g., have the
opposite sign). This confounded effect of SNP1 on lifespan may
be successfully replicated in the new genetic association study if
the level of LD between SNP1 and SNP2 and other parameters of
genetic structure in both populations are about the same. Such
replication, however, does not guarantee proper interpretation
of the effect of SNP1 on lifespan because it is confounded by
the effect of SNP2 and depends on the LD level between two
SNPs. This also means that analyses of next (third) population
with a different LD level between SNP1 and SNP2 may not
replicate the results of the two earlier studies. One, however,
cannot say that the results of the first two analyses are “more
correct” than the findings from the third study because both are
confounded by the LD with another causal SNP. The estimates
of the pure effect of SNP1 on lifespan can be obtained from the
data on the initial population in which SNP1 and SNP2 were
not in LD.
Better understanding of how human genes regulate
relationships among aging, health, and longevity related
traits will contribute to development of intervention strategies
aiming to increase healthy lifespan and reduce the burden of
chronic non-communicable diseases. A number of promising
genetic associations with human longevity related traits were
detected in GWAS and confirmed in other populations (Willcox
et al., 2008; Deelen et al., 2011; Nebel et al., 2011; Flachsbart
et al., 2013; Soerensen et al., 2013, 2015; Broer et al., 2015).
At the same time, numerous attempts to replicate many other
detected associations with these traits failed (Novelli et al., 2008).
Elbaz and colleagues could not replicate 13 SNPs significantly
associated with Parkinson’s disease (Elbaz et al., 2006). Campa
and colleagues could not replicate seven loci associated with
the risk of pancreatic cancer detected in studies of two Asian
populations (Campa et al., 2013). Suarez–Gestal and colleagues
were not able to replicate significant associations between
16 SNPs and responses to specific treatments of rheumatoid
arthritis (Suarez-Gestal et al., 2010). Nemr and colleagues could
not replicate association of EXT2 genetic variants with the risk
of type 2 diabetes in a population of Lebanese Arabs (Nemr
et al., 2013). Such persistent non-replication of the results of
genetic association studies raises legitimate questions about
the factors and mechanisms responsible. Previous research has
identified a number of conditions that may contribute to the
lack of replication (Ioannidis, 2007; Kavvoura and Ioannidis,
2008; Kraft et al., 2009; Ukraintseva et al., 2016). In this paper,
we demonstrated that differences in genetic structures between
various study populations can make substantial contributions to
the non-replication of the results of genetic association studies of
human longevity.
AUTHOR CONTRIBUTIONS
AY and SU conceived the paper and wrote the first draft.
IZ developed software for simulations and together with AY
performed simulation experiments. LA and KA performed LD
analyses. ArY, KA, and ES provide valuable comments and
suggestions and together with DW, MK, AK, IK, IA make
valuable contributions to the discussion section. All coauthors
participated equally in preparing the ultimate version of the
manuscript and Supplementary materials.
ACKNOWLEDGMENTS
Research reported in this publication was supported by the
NIA/NIH grants R01AG046860, P01AG043352, P30AG034424,
and 5U01AG023712-10 (LLFS). The results of this paper
were discussed at the conference call of the Research and
Development (R&D) Committee of the Long Life Family Study
(LLFS) group. The paper does not necessarily reflect the opinions
or views of the entire LLFS group. The content is solely the
responsibility of the authors and does not necessarily represent
Frontiers in Genetics | www.frontiersin.org 6 November 2016 | Volume 7 | Article 188
Yashin et al. Causal SNPs in Longevity
the official views of the National Institutes of Health. MESA
and the MESA SHARe project are conducted and supported
by the National Heart, Lung, and Blood Institute (NHLBI) in
collaboration with MESA investigators. Support for MESA is
provided by contracts N01-HC-95159, N01-HC-95160, N01-
HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164,
N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-
95168, N01-HC-95169, and CTSA UL1-RR-024156. Funding
for SHARe genotyping was provided by NHLBI Contract
N02-HL-64278. Genotyping was performed at Affymetrix (Santa
Clara, California, USA) and the Broad Institute of Harvard
and MIT (Boston, Massachusetts, USA) using the Affymetric
Genome-Wide Human SNP Array 6.0. The authors thank Debra
Fincham for help in preparing this paper for publication.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fgene.
2016.00188/full#supplementary-material
REFERENCES
Aissani, B. (2014). Confounding by linkage disequilibrium. J. Hum. Genet. 59,
110–115. doi: 10.1038/jhg.2013.130
Atzmon, G., Rincon, M., Schechter, C. B., Shuldiner, A. R., Lipton, R. B., Bergman,
A., et al. (2006). Lipoprotein genotype and conserved pathway for exceptional
longevity in humans. PLoS Biol. 4:e113. doi: 10.1371/journal.pbio.0040113
Bergman, A., Atzmon, G., Ye, K., MacCarthy, T., and Barzilai, N. (2007).
Buffering mechanisms in aging: a systems approach toward uncovering
the genetic component of aging. PLoS Comput. Biol. 3:e170. doi:
10.1371/journal.pcbi.0030170
Broer, L., Buchman, A. S., Deelen, J., Evans, D. S., Faul, J. D., Lunetta, K. L.,
et al. (2015). GWAS of longevity in CHARGE consortium confirms APOE
and FOXO3 candidacy. J. Gerontol. A Biol. Sci. Med. Sci. 70, 110–118. doi:
10.1093/gerona/glu166
Campa, D., Rizzato, C., Bauer, A. S., Werner, J., Capurso, G., Costello, E.,
et al. (2013). Lack of replication of seven pancreatic cancer susceptibility loci
identified in two Asian populations. Cancer Epidemiol. Biomarkers Prev. 22,
320–323. doi: 10.1158/1055-9965.EPI-12-1182
Cantor, R. M., Lange, K., and Sinsheimer, J. S. (2010). Prioritizing GWAS results: a
review of statistical methods and recommendations for their application. Am.
J. Hum. Genet. 86, 6–22. doi: 10.1016/j.ajhg.2009.11.017
Charles, B. A., Shriner, D., and Rotimi, C. N. (2014). Accounting for linkage
disequilibrium in association analysis of diverse populations. Genet. Epidemiol.
38, 265–273. doi: 10.1002/gepi.21788
Clarke, G. M., Carter, K. W., Palmer, L. J., Morris, A. P., and Cardon, L. R. (2007).
Fine mapping versus replication in whole-genome association studies. Am. J.
Hum. Genet. 81, 995–1005. doi: 10.1086/521952
Deelen, J., Beekman, M., Uh, H. W., Helmer, Q., Kuningas, M., Christiansen, L.,
et al. (2011). Genome-wide association study identifies a single major locus
contributing to survival into old age; the APOE locus revisited. Aging Cell 10,
686–698. doi: 10.1111/j.1474-9726.2011.00705.x
Elbaz, A., Nelson, L. M., Payami, H., Ioannidis, J. P., Fiske, B. K., Annesi, G.,
et al. (2006). Lack of replication of thirteen single-nucleotide polymorphisms
implicated in Parkinson’s disease: a large-scale international study. Lancet
Neurol. 5, 917–923. doi: 10.1016/S1474-4422(06)70579-8
Flachsbart, F., Möller, M., Däumer, C., Gentschew, L., Kleindorp, R., Krawczak,
M., et al. (2013). Genetic investigation of FOXO3A requires special attention
due to sequence homology with FOXO3B. Eur. J. Hum. Genet. 21, 240–242.
doi: 10.1038/ejhg.2012.83
Garner, C., and Slatkin, M. (2003). On selecting markers for association studies:
patterns of linkage disequilibrium between two and three diallelic loci. Genet.
Epidemiol. 24, 57–67. doi: 10.1002/gepi.10217
Gorroochurn, P., Hodge, S. E., Heiman, G. A., Durner, M., and Greenberg, D. A.
(2007). Non-replication of association studies: “pseudo-failures” to replicate?
Genet. Med. 9, 325–331. doi: 10.1097GIM.0b013e3180676d79
Greene, C. S., Penrod, N. M., Williams, S. M., and Moore, J. H. (2009). Failure
to replicate a genetic association may provide important clues about genetic
architecture. PLoS ONE 4:e5639. doi: 10.1371/journal.pone.0005639
Hart, A. B., de Wit, H., and Palmer, A. A. (2013). Candidate gene
studies of a promising intermediate phenotype: failure to replicate.
Neuropsychopharmacology 38, 802–816. doi: 10.1038/npp.2012.245
Hassanein, M. T., Lyon, H. N., Nguyen, T. T., Akylbekova, E. L., Waters, K., Lettre,
G., et al. (2010). Fine mapping of the association with obesity at the FTO
locus in African-derived populations. Hum. Mol. Genet. 19, 2907–2916. doi:
10.1093/hmg/ddq178
Hayes, B. (2013). Overview of statistical methods for genome-wide association
studies (GWAS).Methods Mol. Biol. 1019, 149–169. doi: 10.1007/978-1-62703-
447-0_6
Hormozdiari, F., Kichaev, G., Yang, W. Y., Pasaniuc, B., and Eskin, E. (2015).
Identification of causal genes for complex traits. Bioinformatics 31, i206–i213.
doi: 10.1093/bioinformatics/btv240
Hormozdiari, F., Kostem, E., Kang, E. Y., Pasaniuc, B., and Eskin, E. (2014).
Identifying causal variants at loci with multiple signals of association. Genetics
198, 497–508. doi: 10.1534/genetics.114.167908
Ioannidis, J. P. A. (2007). Non-replication and inconsistency in the genome-wide
association setting. Hum. Hered. 64, 203–213. doi: 10.1159/000103512
Ioannidis, J. P. A. (2015). Failure to replicate: sound the alarm. Cerebrum 2015:cer-
12a-15.
Kavvoura, F. K., and Ioannidis, J. P. (2008). Methods for meta-analysis in genetic
association studies: a review of their potential and pitfalls. Hum. Genet. 123,
1–14. doi: 10.1007/s00439-007-0445-9
Kichaev, G., Yang, W. Y., Lindstrom, S., Hormozdiari, F., Eskin, E., Price,
A. L., et al. (2014). Integrating functional data to prioritize causal
variants in statistical fine-mapping studies. PLoS Genet. 10:e1004722. doi:
10.1371/journal.pgen.1004722
Kim, K. S., Kim, G. S., Hwang, J. Y., Lee, H. J., Park, M. H., Kim, K. J., et al. (2007).
Single nucleotide polymorphisms in bone turnover-related genes in Koreans:
ethnic differences in linkage disequilibrium and haplotype. BMC Med. Genet.
8:70. doi: 10.1186/1471-2350-8-70
Koda, Y., Tachida, H., Soejima, M., Takenaka, O., and Kimura, H. (2004).
Population differences in DNA sequence variation and linkage disequilibrium
at the PON1 gene. Ann. Hum. Genet. 68(Pt 2), 110–119. doi: 10.1046/j.1529-
8817.2003.00077.x
Kraft, P., Zeggini, E., and Ioannidis, J. P. (2009). Replication in genome-wide
association studies. Stat. Sci. 24, 561–573. doi: 10.1214/09-STS290
Lin, P. I., Vance, J. M., Pericak-Vance, M. A., and Martin, E. R. (2007). No gene
is an island: the flip-flop phenomenon. Am. J. Hum. Genet. 80, 531–538. doi:
10.1086/512133
Liu, J., Lewinger, J. P., Gilliland, F. D., Gauderman, W. J., and Conti, D. V. (2013).
Confounding and heterogeneity in genetic association studies with admixed
populations. Am. J. Epidemiol. 177, 351–360. doi: 10.1093/aje/kws234
Lohmueller, K. E., Wong, L. J. C., Mauney, M. M., Jiang, L., Felder, R. A., Jose P. A.
et al. (2006). Patterns of genetic variation in the hypertension candidate gene
GRK4: ethnic variation and haplotype structure. Ann. Hum. Genet. 70(Pt 1),
27–41. doi: 10.1111/j.1529-8817.2005.00197.x
Maxwell, S. E., Lau, M. Y., and Howard, G. S. (2015). Is psychology suffering from
a replication crisis? What does “failure to replicate” really mean? Am. Psychol.
70, 487–498. doi: 10.1037/a0039400
Moore, J. H., Asselbergs, F. W., and Williams, S. M. (2010). Bioinformatics
challenges for genome-wide association studies. Bioinformatics 26, 445–455.
doi: 10.1093/bioinformatics/btp713
Morris, A. P. (2014). Finemapping of type 2 diabetes susceptibility loci.Curr. Diab.
Rep. 14, 549. doi: 10.1007/s11892-014-0549-2
Frontiers in Genetics | www.frontiersin.org 7 November 2016 | Volume 7 | Article 188
Yashin et al. Causal SNPs in Longevity
Nebel, A., Kleindorp, R., Caliebe, A., Nothnagel, M., Blanché, H., Junge, O., et al.
(2011). A genome-wide association study confirms APOE as the major gene
influencing survival in long-lived individuals.Mech. Ageing Dev. 132, 324–330.
doi: 10.1016/j.mad.2011.06.008
Nemr, R., Al-Busaidi, A. S., Sater, M. S., Echtay, A., Saldanha, F. L., Racoubian,
E., et al. (2013). Lack of replication of common EXT2 gene variants with
susceptibility to type 2 diabetes in Lebanese Arabs.DiabetesMetab. 39, 532–536.
doi: 10.1016/j.diabet.2013.05.001
Novelli, V., Viviani Anselmi, C., Roncarati, R., Guffanti, G., Malovini, A., Piluso,
G., et al. (2008). Lack of replication of genetic associations with human
longevity. Biogerontology 9, 85–92. doi: 10.1007/s10522-007-9116-4
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A.,
and Reich, D. (2006). Principal components analysis corrects for stratification
in genome-wide association studies. Nat. Genet. 38, 904–909. doi: 10.1038/
ng1847
Price, A. L., Zaitlen, N. A., Reich, D., and Patterson, N. (2010). New approaches to
population stratification in genome-wide association studies. Nat. Rev. Genet.
11, 459–463. doi: 10.1038/nrg2813
Sawyer, S. L., Mukherjee, N., Pakstis, A. J., Feuk, L., Kidd, J. R., Brookes, A. J., et al.
(2005). Linkage disequilibrium patterns vary substantially among populations.
Eur. J. Hum. Genet. 13, 677–686. doi: 10.1038/sj.ejhg.5201368
Shen, H., Liu, Y., Liu, P., Recker, R. R., and Deng, H. W. (2005). Nonreplication
in genetic studies of complex diseases–lessons learned from studies of
osteoporosis and tentative remedies. J. Bone Miner. Res. 20, 365–376. doi:
10.1359/JBMR.041129
Shifman, S., Kuypers, J., Kokoris, M., Yakir, B., and Darvasi, A. (2003). Linkage
disequilibrium patterns of the human genome across populations. Hum. Mol.
Genet. 12, 771–776. doi: 10.1093/hmg/ddg088
Soerensen, M., Dato, S., Tan, Q., Thinggaard, M., Kleindorp, R., Beekman, M.,
et al. (2013). Evidence from case-control and longitudinal studies supports
associations of genetic variation in APOE, CETP, and IL6 with human
longevity. Age (Dordr) 35, 487–500. doi: 10.1007/s11357-011-9373-7
Soerensen, M., Nygaard, M., Dato, S., Stevnsner, T., Bohr, V. A., Christensen,
K., et al. (2015). Association study of FOXO3A SNPs and aging phenotypes
in Danish oldest-old individuals. Aging Cell 14, 60–66. doi: 10.1111/acel.
12295
Suarez-Gestal, M., Perez-Pampin, E., Calaza, M., Gomez-Reino, J. J., and Gonzalez,
A. (2010). Lack of replication of genetic predictors for the rheumatoid arthritis
response to anti-TNF treatments: a prospective case-only study. Arthritis Res.
Ther. 12, R72. doi: 10.1186/ar2990
Teo, Y. Y., and Sim, X. (2010). Patterns of linkage disequilibrium in different
populations: implications and opportunities for lipid-associated loci identified
from genome-wide association studies. Curr. Opin. Lipidol. 21, 104–115. doi:
10.1097/MOL.0b013e3283369e5b
Thompson, E. E., Sun, Y., Nicolai, D., and Ober, C. (2010). Shades of gray:
a comparison of linkage disequilibrium between Hutterites and Europeans.
Genet. Epidemiol. 34, 133–139. doi: 10.1002/gepi.20442
Torrico, B., Chiocchetti, A. G., Bacchelli, E., Trabetti, E., Hervás, A., Franke, B.,
et al. (2016). Lack of replication of previous autism spectrum disorder GWAS
hits in European populations. Autism Res. doi: 10.1002/aur.1662. [Epub ahead
of print].
Ukraintseva, S., Yashin, A., Arbeev, K., Kulminski, A., Akushevich, I., Wu, D., et al.
(2016). Puzzling role of genetic risk factors in human longevity: “risk alleles” as
pro-longevity variants. Biogerontology 17, 109–127. doi: 10.1007/s10522-015-
9600-1
Wacholder, S., Rothman, N., and Caporaso, N. (2000). Population stratification in
epidemiologic studies of common genetic variants and cancer: quantification
of bias. J. Natl. Cancer Inst. 92, 1151–1158. doi: 10.1093/jnci/92.14.1151
Willcox, B. J., Donlon, T. A., He, Q., Chen, R., Grove, J. S., Yano, K., et al. (2008).
FOXO3A genotype is strongly associated with human longevity. Proc. Natl.
Acad. Sci. U.S.A. 105, 13987–13992. doi: 10.1073/pnas.0801030105
Yashin, A. I., De Benedictis, G., Vaupel, J. W., Tan, Q., Andreev, K. F., Iachine,
I. A., et al. (1999). Genes, demography, and life span: the contribution of
demographic data in genetic studies on aging and longevity.Am. J. Hum. Genet.
65, 1178–1193. doi: 10.1086/302572
Yashin, A. I., De Benedictis, G., Vaupel, J. W., Tan, Q., Andreev, K. F., Iachine, I.
A., et al. (2000). Genes and longevity: lessons from studies of centenarians. J.
Gerontol. A Biol. Sci. Med. Sci. 55, B319–B328. doi: 10.1093/gerona/55.7.B319
Zaitlen, N., Pasaniuc, B., Gur, T., Ziv, E., and Halperin, E. (2010). Leveraging
genetic variability across populations for the identification of causal variants.
Am. J. Hum. Genet. 86, 23–33. doi: 10.1016/j.ajhg.2009.11.016
Zapata, C. (2013). Linkage disequilibrium measures for fine-scale mapping of
disease loci are revisited. Front. Genet. 4:228. doi: 10.3389/fgene.2013.00228
Zaykin, D. V., and Shibata, K. (2008). Genetic flip-flop without an accompanying
change in linkage disequilibrium. Am. J. Hum. Genet. 82, 794–796; author reply
796–797. doi: 10.1016/j.ajhg.2008.02.001
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Yashin, Zhbannikov, Arbeeva, Arbeev, Wu, Akushevich, Yashkin,
Kovtun, Kulminski, Stallard, Kulminskaya and Ukraintseva. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Genetics | www.frontiersin.org 8 November 2016 | Volume 7 | Article 188
